Ledger.Open graph →
SEC Form D · filed May 29, 2020

Atea Pharmaceuticals, Inc

Offering
$215.0M
Sold
$107.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Bruce Polsky · Boston, MADirectorJean-Pierre Sommadossi, Ph.D · Boston, MAExec · DirectorBruno Lucidi · Boston, MADirectorAndrea Corcoran · Boston, MAExecBihua Chen · San Diego, CADirectorSimon R. Goldman · San Francisco, CAExecStevan S. Armstrong · Brooklyn, NYExec · DirectorSimon R. Yeh · San Francisco, CADirectorSonia K. Lutchmiah · Moka, O4DirectorSean M. Mcavoy · Burlingame, CADirectorAndrew Hack, M.D., Ph.D · Boston, MADirectorFranklin Berger · San Francisco, CADirectorGrigory Borisenko · SAN DIEGO, CADirectorIsaac Cheng, M.D · Boston, MADirectorBalan R. Ayyar · Brooklyn, NYDirectorA. M. Finkelstein · Newark, NJExec · DirectorJason Rottenberg · Winter Park, FLDirectorEvgeny Zaytsev · San Francisco, CAExecPhilip Sawyer · San Francisco, CADirectorAndrew Hack, M.D., Ph.D · Boston, MADirectorFranklin Berger · Framingham, MADirectorGrigory Borisenko · SAN DIEGO, CADirectorIsaac Cheng, M.D · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗